Thermo Fisher Scientific Reports Third Quarter 2021 Results

WALTHAM, Mass., Oct. 27, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 2, 2021. Third Quarter 2021 Highlights Third quarter revenue increased 9% to $9.33 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.79. Third... Read more

Unchained Labs blasts Big Kahuna and Junior into the future, launches LEA 10!

October 19, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, released its LEA 10 automation software today – making Big Kahuna and Junior even more ready to plow through scientific challenges and workflow bottlenecks. Big Kahuna and Junior are workhorses that labs rely... Read more

Eppendorf AG completes conversion to European public limited company

19.10.2021 Hamburg, October 2021 • Conversion to SE (“Societas Europaea”) completed • No impact on current business• Group headquarter remains in Hamburg, Germany The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE... Read more

SPT Labtech integrates recent acquisitions into unified brand and portfolio

12/10/2021 SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, unveils new branding that brings together its technologies with those from recent acquisitions into a single entity. The merged portfolio and positioning reflect SPT Labtech’s commitment to harnessing the ingenuity and product development track record... Read more

PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 7, 2021– PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. Qualified laboratories can immediately begin using this... Read more

Brooks Automation and Cleveland Clinic Celebrate Opening of Biobanking Facility

22,000-square-foot ultra-cold and cryogenic storage facility will enhance researchers’ study to accelerate breakthroughs and optimize patient care CLEVELAND and CHELMSFORD, Mass., Oct. 7, 2021 /PRNewswire/ —  Brooks Automation, Inc. (Nasdaq: BRKS) and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus. The two-story biorepository is managed... Read more

EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 5, 2021– EUROIMMUN, a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S. Food and Drug Administration has provided Emergency Use Authorization (EUA) for its Anti-SARS-CoV-2 S1 CurveTM ELISA (IgG). This assay allows... Read more

PerkinElmer Introduces Next Generation Cell Image Analysis and Management Software Platform to Help Streamline Drug Discovery Decision Making

Signals Image Artist helps scientists process and analyze 3D cell imaging, phenotypic and cell painting data in hours vs. days or weeks October 4, 2021 WHAT: PerkinElmer, Inc ., a global leader committed to innovating for a healthier world, today announced the launch of Signals Image Artist™ software, a next generation image analysis and management... Read more

Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021

Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021 New instruments, assays and controls improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell & gene therapy, autoimmune disease and drugs of abuse ATLANTA, Sept. 28, 2021 /PRNewswire/ — AACC 2021 –Thermo Fisher Scientific, the world leader in... Read more